A court in Baltimore has ordered…
A court in Baltimore has ordered Johnson & Johnson to [...]
A court in Baltimore has ordered Johnson & Johnson to [...]
A patient in an open label extension study of Pfizer’s [...]
Neurocrine’s Ingrezza, approved to treat certain uncontrolled movements, failed to [...]
William Blair has hand-picked its top five stock recommendations for [...]
Drug pricing, layoffs, personnel moves and other topics drove reader [...]
Hope Biosciences has linked its stem cell therapy candidate to [...]
Pharma giant AstraZeneca extended its supply deal with Michigan-based medical [...]
Despite a year of trade tensions, national security strictures and [...]
Six people, including a former employee of investment bank Citigroup’s [...]
CMS’ Innovation Center has released two new drug pricing models [...]